nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Artificial neural network systems to predict the response to sintilimab in squamous-cell non-small-cell lung cancer based on data of ORIENT-3 study
|
Xie, Tongji |
|
|
74 |
1 |
|
artikel |
2 |
Breaking the shield of solid tumors: a combined approach for enhanced efficacy of CAR-T cells
|
Khaliulin, Marat |
|
|
74 |
1 |
|
artikel |
3 |
Clinical outcomes of chimeric antigen receptor T-cell therapy following autologous hematopoietic stem cell transplantation in 38 patients with refractory/relapsed primary or secondary central nervous system lymphoma
|
Wu, Jiaying |
|
|
74 |
1 |
|
artikel |
4 |
Combination of ataxia telangiectasia and Rad3-related inhibition with ablative radiotherapy remodels the tumor microenvironment and enhances immunotherapy response in lung cancer
|
Chen, Jenny Ling-Yu |
|
|
74 |
1 |
|
artikel |
5 |
Correction: Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma: Results of the phase II PRIMMO study
|
De Jaeghere, Emiel A. |
|
|
74 |
1 |
|
artikel |
6 |
Correction: Risk factors indicating immune-related adverse events with combination chemotherapy with immune checkpoint inhibitors and platinum agents in patients with non-small cell lung cancer: a multicenter retrospective study
|
Fujimoto, Airi |
|
|
74 |
1 |
|
artikel |
7 |
Correction: The performance status gap in immunotherapy for frail patients with advanced non-small cell lung cancer
|
Wu, Julie Tsu-Yu |
|
|
74 |
1 |
|
artikel |
8 |
COVID-19–sensitive tumour response: 2-year assessment of the SARS-CoV-2 humoral response in cancer patients in oncology hospital in Poland
|
Kosiorek, Piotr |
|
|
74 |
1 |
|
artikel |
9 |
Cryo-thermal therapy reshaped the tumor immune microenvironment to enhance the efficacy of adoptive T cell therapy
|
Wang, Shicheng |
|
|
74 |
1 |
|
artikel |
10 |
Dendritic cell maturation is induced by p53-armed oncolytic adenovirus via tumor-derived exosomes enhancing systemic antitumor immunity
|
Ohtani, Tomoko |
|
|
74 |
1 |
|
artikel |
11 |
Differences in immune-related toxicity between PD-1 and PD-L1 inhibitors: a retrospective cohort study in patients with advanced cancer
|
Ladjevardi, Cecilia Olsson |
|
|
74 |
1 |
|
artikel |
12 |
Differential T cell accumulation within intracranial and subcutaneous melanomas is associated with differences in intratumoral myeloid cells
|
Stasiak, Katarzyna |
|
|
74 |
1 |
|
artikel |
13 |
Efficacy, safety, and biomarker analysis of TACE combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma: a real-world study
|
Meng, Lingzhan |
|
|
74 |
1 |
|
artikel |
14 |
Hepatic arterial infusion chemotherapy combined with systemic therapy sequentially or simultaneously for advanced hepatocellular carcinoma
|
Cao, Yu-zhe |
|
|
74 |
1 |
|
artikel |
15 |
Hepatitis associated with immune checkpoint inhibitors-based combinations of other therapies: A real-world pharmacovigilance analysis based on the FDA adverse event reporting system (FAERS) database
|
Li, Zhaohui |
|
|
74 |
1 |
|
artikel |
16 |
HLA-G high-expressor 3’UTR markers are linked to gastric cancer development and survival
|
Vaquero-Yuste, Christian |
|
|
74 |
1 |
|
artikel |
17 |
Immune checkpoint inhibitors-related thyroid dysfunction: influencing factor analysis, prediction model development, and management strategy proposal
|
Li, Xinya |
|
|
74 |
1 |
|
artikel |
18 |
Immunological differences between monophasic and biphasic synovial sarcoma with implications for immunotherapy
|
Luk, S. J. |
|
|
74 |
1 |
|
artikel |
19 |
Integrated multi-omics analysis reveals clinical significance of hepatocyte nuclear factor-1β in tumor immune microenvironment, immunotherapy and prognostic prediction for colon adenocarcinoma
|
Gao, Fushan |
|
|
74 |
1 |
|
artikel |
20 |
Integration of bulk and single-cell RNA-seq reveals prognostic gene signatures in patients with bladder cancer treated with immune checkpoint inhibitors
|
Cho, Mina |
|
|
74 |
1 |
|
artikel |
21 |
Interdependence of coagulation with immunotherapy and BRAF/MEK inhibitor therapy: results from a prospective study
|
Beckmann, Malte |
|
|
74 |
1 |
|
artikel |
22 |
Intratumoural CD8+ CXCR5+ follicular cytotoxic T cells have prognostic value and are associated with CD19+ CD38+ B cells and tertiary lymphoid structures in colorectal cancer
|
Wei, Fangze |
|
|
74 |
1 |
|
artikel |
23 |
Loop33 × 123 CAR-T targeting CD33 and CD123 against immune escape in acute myeloid leukemia
|
Ma, Haotian |
|
|
74 |
1 |
|
artikel |
24 |
Ly6E on tumor cells impairs anti-tumor T-cell responses: a novel mechanism of tumor-induced immune exclusion
|
Hailin, Lan |
|
|
74 |
1 |
|
artikel |
25 |
New insights into the immunomodulatory potential of sialic acid on monocyte-derived dendritic cells
|
Silva, Zélia |
|
|
74 |
1 |
|
artikel |
26 |
Nicotine promotes M2 macrophage polarization through α5-nAChR/SOX2/CSF-1 axis in lung adenocarcinoma
|
Kang, Guiyu |
|
|
74 |
1 |
|
artikel |
27 |
NLRP12/C1qA positive feedback in tumor-associated macrophages regulates immunosuppression through LILRB4/NF-κB pathway in lung adenocarcinoma
|
Yin, Jiaxin |
|
|
74 |
1 |
|
artikel |
28 |
Overcoming immunosuppression in cancer: how ketogenic diets boost immune checkpoint blockade
|
Stefan, Victoria E. |
|
|
74 |
1 |
|
artikel |
29 |
Periodontitis promotes tumor growth and immune evasion via PD-1/PD-L1
|
Wang, Suli |
|
|
74 |
1 |
|
artikel |
30 |
Phenotypic insights into genetic risk factors for immune-related adverse events in cancer immunotherapy
|
Ma, Haochuan |
|
|
74 |
1 |
|
artikel |
31 |
Pretransplant immunotherapy increases acute rejection yet improves survival outcome of HCC patients with MVI post-liver transplantation
|
Lu, Xinjun |
|
|
74 |
1 |
|
artikel |
32 |
Q11, a CYP2E1 inhibitor, exerts anti-hepatocellular carcinoma effect by inhibiting M2 macrophage polarization
|
Zhang, Cunzhen |
|
|
74 |
1 |
|
artikel |
33 |
Spontaneous high clonal expansion of Wilms’ tumor gene 1-specific cytotoxic T-lymphocytes in patients with Wilms’ tumor gene 1-expressing solid tumor
|
Morimoto, Soyoko |
|
|
74 |
1 |
|
artikel |
34 |
Targeting OAS3 for reversing M2d infiltration and restoring anti-tumor immunity in pancreatic cancer
|
Zhang, Shaopeng |
|
|
74 |
1 |
|
artikel |
35 |
Target trial emulation to evaluate the effect of immune-related adverse events on outcomes in metastatic urothelial cancer
|
Pichler, Renate |
|
|
74 |
1 |
|
artikel |
36 |
Three-dimensional dynamics of mesothelin-targeted CAR.CIK lymphocytes against ovarian cancer peritoneal carcinomatosis
|
Galvagno, Federica |
|
|
74 |
1 |
|
artikel |
37 |
“Tumor immunology meets oncology” (TIMO), 18 April–20 April 2024, in Brandenburg an der Havel, Germany
|
Seliger, Barbara |
|
|
74 |
1 |
|
artikel |
38 |
Uncovering the role of tumor cGAS expression in predicting response to PD-1/L1 inhibitors in non-small cell lung cancer
|
Ozawa, Yuichi |
|
|
74 |
1 |
|
artikel |